This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....